Level C· Early human research exploring benefitsRetrospective StudyEurope PMCOpen access

Subsequent vertebral fracture after percutaneous vertebroplasty or kyphoplasty in postmenopausal women with osteoporotic vertebral compression fracture

Zhang Q., Cheng Y., Chen F.

Retrospective Study on Back & Spine, published in Front Endocrinol (Lausanne) (2026) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Retrospective Study
Journal
Front Endocrinol (Lausanne) (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41767384
PMCID
PMC12935631
DOI
10.3389/fendo.2026.1716002

Abstract (original English)

Background Subsequent vertebral fracture (SVF) as a severe complication of percutaneous vertebroplasty (PVP) or percutaneous kyphoplasty (PKP) for the treatment of osteoporotic vertebral compression fracture (OVCF) is a major public health challenge. Risk factors of SVF following initial PVP or PKP surgery in postmenopausal women are still controversial. This study aims to investigate the risk factors of SVF after initial PVP or PKP for single-level OVCF in postmenopausal women. Methods Postmenopausal women who were initially treated with PVP or PKP for single-level OVCF were retrospectively analyzed. The patients were divided into SVF group and control group based on whether they had SVF or not. Demographic, surgery-related and radiographic data were recorded from electronic medical records or radiographic examinations. Univariate and multivariate logistic regression analysis were conducted to determine the independent risk factors. Results A total of 528 postmenopausal women who met the inclusion and exclusion criteria were included in this study, and 73 postmenopausal women experienced SVF after PVP or PKP. Logistic regression analysis demonstrated that low BMI (OR = 0.905; 95% CI = 0.829-0.987, P = 0.025), previous fracture history (OR = 1.899; 95% CI = 1.046-3.449, P = 0.035) and low BMD (OR = 0.977; 95% CI = 0.966-0.988, P Conclusions Low BMI, previous vertebral fracture

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
HumansOsteoporosis, PostmenopausalSpinal FracturesPostoperative ComplicationsRisk FactorsRetrospective StudiesPostmenopauseAgedMiddle AgedFemale

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research